2m 2m 2m 2m 2m 2m 2m
Omeros (OMER)
NASDAQ
$18.09+$0.79 (+4.57%)
Price as of Nov 11, 2026 7:30 PM EST- $1.3BMarket Cap
- 151.09%1-Year Change
- BiotechnologyIndustry
Omeros (OMER)
$18.09+$0.79 (+4.57%)
OMER | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.30 | ||
Change | -$0.25 (-1.42%) | ||
Open | $17.45 | ||
High | $17.84 | ||
Low | $17.06 | ||
Previous Close | $17.55 | ||
Volume | 683,728 | ||
30-Day Average Volume | 1,140,198 | ||
1-Week Change | -5.31% | ||
1-Month Change | -12.76% | ||
1-Year Change | 151.09% | ||
3-Year Change | 1,284.00% | ||
5-Year Change | 115.44% | ||
Fundamentals | |||
Shares Outstanding | 72.4M | ||
Total Assets | $286.8M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $28.5M | ||
Net Income | $13.2M | ||
Free Cash Flow | $4.1M | ||
EBIT | $16.4M | ||
EBITDA | $16.6M | ||
Net Working Capital | $90.3M | ||
EPS | $0.15 | ||
Enterprise Value/EBITDA | 82 | ||
Enterprise Value/Revenue | 48 | ||
P/B | -24 | ||
P/E | 115 | ||
PEG | -2 | ||
Price/Free Cash Flow | 305 | ||
Price/Operating Cash Flow | 302 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue